Allemannsdata Wiki
Manual search

AMBR INSTITUTE AS

Organization number 831163542 · Aksjeselskap

Programmatic access to company data (JSON)

Source: Firmafakta. Data read and page generated 2026-09-09T20:08:38Z. HTML cache: no-store (TTL 0 seconds). Default TTL for Firmafakta JSON/API responses: 60 seconds.

Facts

Source: Firmafakta, with business data from public registers.

organisasjonsnummer:
831163542
navn:
AMBR INSTITUTE AS
organisasjonsform:
kode:
AS
beskrivelse:
Aksjeselskap
naeringskode1:
kode:
62.100
beskrivelse:
Dataprogrammeringstjenester
antallAnsatte:
5
hjemmeside:
not reported by source
epostadresse:
not reported by source
telefon:
not reported by source
forretningsadresse:
adresse:
Karenslyst allé 2
poststed:
OSLO
postnummer:
0278
kommune:
OSLO
stiftelsesdato:
2023-03-27
registreringsdatoenhetsregisteret:
2023-04-04
aktivitet:
Programmering.
vedtektsfestetFormaal:
Utvikle og tilby programvare og programmeringstjenester, samt å foreta, investeringer i forbindelse med dette.

View the address in Geonorge

Board and other roles

Source: Firmafakta. Also see the separate Brønnøysund lookup under related lookups.

Daglig leder

Styre

Owners

Source: Firmafakta shareholder dataset.

  1. INTELLECTUAL LABS AS – 65.03 % (197357 shares, share class: Ordinære aksjer)
  2. VALENTIN ANDRE NORMAND – 14.83 % (45000 shares, share class: Ordinære aksjer)
  3. DIGITAL INSIGHT AS – 5.63 % (17100 shares, share class: Ordinære aksjer)
  4. IRANTZU ANZAR MARTINEZ DE LAGRAN – 3.95 % (12000 shares, share class: Ordinære aksjer)
  5. SNEFRED INVEST AS – 2.41 % (7300 shares, share class: Ordinære aksjer)
  6. UROBOROS AS – 1.51 % (4581 shares, share class: Ordinære aksjer)
  7. MIDTFJORD AS – 1.48 % (4500 shares, share class: Ordinære aksjer)
  8. NILGUN GRINI – 1.48 % (4500 shares, share class: Ordinære aksjer)
  9. PUSHPENDRA KUMAR SINGH – 1.02 % (3108 shares, share class: Ordinære aksjer)
  10. HILDE GRØNNINGSÆTER – 1.01 % (3054 shares, share class: Ordinære aksjer)
  11. LARS AUKRUST – 0.66 % (2000 shares, share class: Ordinære aksjer)
  12. PAUL LOUIS ISKE – 0.66 % (2000 shares, share class: Ordinære aksjer)
  13. HILDE LOGE NILSEN – 0.33 % (1000 shares, share class: Ordinære aksjer)

Fetch a longer owner list

Company holdings

No holdings found.

Grants and support

Sources provided through Firmafakta: Innovation Norway, the EU, the Research Council of Norway and SkatteFUNN.

Innovasjon Norge (1)

1 results

  1. fylkesnavn:
    Oslo
    kommunenavn:
    Oslo
    org_nr:
    831163542
    bedriftsnavn:
    AMBR INSTITUTE AS
    virkemiddelkategori:
    Oppstartstilskudd
    underkategori:
    Landsdekkende etablerertilskudd
    innvilget_belop:
    994000
    innvilget_dato:
    06.03.25
    beslutningsenhet:
    IN Øst
    naringshovedgruppe:
    K - Telekommunikasjon, dataprogrammering, konsulentvirksomhet, datainfrastruktur og andre tjenester tilknyttet informasjonsteknologi
    naring:
    62.100 Dataprogrammeringstjenester
    type_finansiering:
    Tilskudd

EU-tildelinger (0)

No registered grants.

Forskningsrådet (2)

2 results

  1. id:
    77517
    prosjektnummer:
    349543
    prosjekttittel:
    Transforming Healthcare: shaping the future of personalised medicine by bringing modular digital twins of patients into hospitals
    prosjektstart:
    2024
    prosjektslutt:
    2026
    prosjektansvarlig_navn:
    PUEROVITA BIOTECHNOLOGY AS
    organisasjonsnummer:
    831163542
    sokt_belop:
    Allmennmedisin
    tildelt_belop:
    0.0
    virkemiddel:
    Programmer
    aktivitet:
    Brukerstyrte innovasjonsprogrammer
  2. id:
    79999
    prosjektnummer:
    354212
    prosjekttittel:
    AI-Driven Multi-Omics Integration for Enhanced Prediction and Personalization in Age-Associated Disease Management
    prosjektstart:
    2024
    prosjektslutt:
    2028
    prosjektansvarlig_navn:
    PUEROVITA BIOTECHNOLOGY AS
    organisasjonsnummer:
    831163542
    sokt_belop:
    Medisinsk teknologi
    tildelt_belop:
    0.0
    virkemiddel:
    Frittstående prosjekter
    aktivitet:
    Andre frittstående prosjekter

SkatteFUNN (3)

3 results

  1. id:
    71928
    innsendt_dato:
    2024-08-31
    prosjektnummer:
    1677
    bedriftsnavn:
    AMBR INSTITUTE AS
    prosjekttittel:
    Forutsigelse av PCa
    organisasjonsnummer:
    831163542
    fylke:
    Oslo
    kommunenavn:
    Oslo
    poststed:
    not reported by source
    soknad_godkjent:
    not reported by source
    soknad_avslatt:
    not reported by source
    vedtaksdato:
    na
    prosjekt_fra_ar:
    2024
    prosjekt_til_ar:
    2026
    sammendrag:
    PueroVita is developing solutions for predictive and personalised medicine for prostate cancer.
  2. id:
    71997
    innsendt_dato:
    2024-08-31
    prosjektnummer:
    2213
    bedriftsnavn:
    AMBR INSTITUTE AS
    prosjekttittel:
    Programvare for prehabilitering og prediksjon av rekonvalesens
    organisasjonsnummer:
    831163542
    fylke:
    Oslo
    kommunenavn:
    Oslo
    poststed:
    not reported by source
    soknad_godkjent:
    not reported by source
    soknad_avslatt:
    not reported by source
    vedtaksdato:
    na
    prosjekt_fra_ar:
    2024
    prosjekt_til_ar:
    2026
    sammendrag:
    PueroVita Biotechnology AS is developing an AI-based software to assist establishing tailored prehabilitation programmes for patients before surgeries and estimate associated surgical risks and recovery. The software will provide a risk index for surgeons to estimate the dangers associated with operation on the patient.
  3. id:
    69632
    innsendt_dato:
    2023-09-01
    prosjektnummer:
    349381
    bedriftsnavn:
    AMBR INSTITUTE AS
    prosjekttittel:
    AgeSpan Product development
    organisasjonsnummer:
    831163542
    fylke:
    Oslo
    kommunenavn:
    Oslo
    poststed:
    OSLO
    soknad_godkjent:
    NEI
    soknad_avslatt:
    JA
    vedtaksdato:
    2023-12-12
    prosjekt_fra_ar:
    2023
    prosjekt_til_ar:
    2025
    sammendrag:
    PueroVita’s AgeSpan is a visionary project that aims to revolutionize personalized medicine and contribute to the digitalization of the healthcare system in Norway and worldwide. Personalized medicine will radically transform the healthcare system in the next decade by integrating multiple information sources about a person’s genetic and lifestyle profile, thus supporting patient specific disease prevention, diagnosis and treatment. AgeSpan’s main goal is to advance personalized medicine by developing proprietary artificial intelligence (AI) algorithms to analyze , process and predict highly useful clinical information based on patient’s biological information (biomarkers). This will open the doors for patient tailored disease risk prediction and treatment recommendations. Furthermore, AgeSpan’s vision is to contribute to a more sustainable and digital health care service by equipping clinicians with user-friendly, digital decision software platforms. Ultimately, healthcare professionals will benefit from more efficient work days and provide patients with specific data-driven disease prevention, treatment and care.

Subunits

Open positions

count:
0
stillinger:

No results.

Related lookups

How an AI agent should use this page

Ground rule: Navigate with HTML GET links to keep explanations and relationships. Use the page's JSON alternative only when concrete values must be extracted, compared or computed.

How to use the company page

  1. Use the organization number as the stable key.
  2. Distinguish between the company's own facts, roles, owners, holdings and grants.
  3. Follow person and company links to explore the graph; do not assume relations that are not explicitly registered.

Related services

Time: Ownership, roles and status can change. State the source and retrieval time with factual claims.

AI agent? Read the complete navigation and programming guide.